New Endometriosis Research Study Seeking Participants - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
New Endometriosis Research Study Seeking Participants New investigational pain medication option being evaluated in the SOLSTICE study


New Endometriosis Research Study Seeking Participants

New investigational pain medication option being evaluated in the SOLSTICE study

PR Newswire

ROCKVILLE, Md., July 9, 2014 /PRNewswire-USNewswire/ -- Most women know all too well the temporary discomfort associated with menstrual cramps. Women with endometriosis, however, suffer with pain that can be debilitating —not just during their period, but sometimes even during other times of the month. Although it may be easy to misunderstand how extreme the symptoms and pain of endometriosis are and dismiss the symptoms as "just some bad cramps," women with endometriosis are seeking treatment options that can effectively manage the pain that may prevent them from doing the things they normally do. A new clinical research study, called the SOLSTICE study, is evaluating an investigational drug for moderate to severe endometriosis pain symptoms.

The symptoms of endometriosis include extremely painful periods, chronic pelvic pain, and pain associated with sexual activity. Most women suffer through the symptoms of endometriosis for a long time (up to 10 years) before receiving a correct diagnosis and may have been treated with analgesic medications, hormone treatment and possibly surgery. Approximately 5.5 million women in the United States have endometriosis.

Because many women with endometriosis suffer misdiagnosed, untreated, or in silence, additional research is needed that may help manage this disease. Clinical research studies test the safety and effectiveness of investigational medications for diseases and conditions to see if they work and if they are safe. People volunteer to participate in clinical studies, and these studies play an important role in the development of future new medications. Many approved drugs, therapies, and devices that are used today are the result of past clinical research studies.

The SOLSTICE study is being conducted at approximately 240 research centers worldwide. About 800 women will participate in the study. You may be able to join the SOLSTICE study if you have been surgically diagnosed with endometriosis, are 18 to 49 years old, and are experiencing moderate to severe pain caused by endometriosis.

To learn more about the SOLSTICE study, to find doctors who are conducting the study, or to find out if you may be eligible to participate, visit www.SolsticeResearchStudy.com or call 888-633-8910.

SOURCE SOLSTICE study

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
7%
Create entirely its own pathway program?
7%
View Results
Untitled Document

Click here